COMMUNIQUÉS West-GlobeNewswire

Saniona publishes its interim report for the first quarter 2018

24/05/2018 - 08:00

PRESS RELEASE May 24, 2018 Financial highlights Q1 2018 (Q1 2017) Net revenues were SEK 4.3 M (7.5 M) EBIT was SEK -15.7 M (-7.6 M) Net profit/loss was SEK -13.5 M (-6.4 M) Earnings per share were SEK -0.62 (-0.31) [...]

Bavarian Nordic Announces Interim Results for the First Three Months of 2018

24/05/2018 - 07:43

COPENHAGEN, Denmark, May 24, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first three months of 2018. First quarter highlights and [...]

Sandoz receives European Commission approval for Zessly® (infliximab) in gastroenterological, rheumatological and dermatological diseases

24/05/2018 - 07:01

European Commission's (EC) approval based on comprehensive data package confirming that Zessly ® matches safety, efficacy and quality of reference medicine Biosimilars such as Zessly enable earlier patient access to [...]

Scholar Rock Announces Pricing of Initial Public Offering

24/05/2018 - 03:52

CAMBRIDGE, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ: SRRK ), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in [...]

Arcturus Therapeutics Comments on Court Ruling on Undisclosed Group Organized by Joseph E. Payne and his Associates in Violation of Regulation 13D

24/05/2018 - 03:45

California Federal Court Rules that Arcturus is Likely to Succeed on Merits of its Claims Against Payne Further Violations by Payne and His Associates Enjoined to Permit all Arcturus Shareholders to Have a Fully [...]

Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering

24/05/2018 - 03:13

HAMILTON, Bermuda, May 23, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (“Kiniksa”) announced today the pricing of its initial public offering of 8,477,777 Class A common shares at a public offering price of $ [...]

Melinta Therapeutics Announces Pricing of Public Offering of Common Stock

24/05/2018 - 03:07

NEW HAVEN, Conn., May 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

Allscripts to deliver anesthesia solution across SingHealth healthcare institutions

24/05/2018 - 02:00

SINGAPORE, May 23, 2018 (GLOBE NEWSWIRE) -- Singapore’s largest public healthcare group, SingHealth, has partnered with Allscripts (NASDAQ: MDRX ) to implement iPro Anesthesia across the Group. The advanced software [...]

Adventist Health Appoints Rick Rawson as President of Rideout Health

24/05/2018 - 00:16

MARYSVILLE, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- Adventist Health announced today the appointment of Rick Rawson as the new president of Rideout Health, serving the Marysville and Yuba City communities. Rawson has [...]

Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine

23/05/2018 - 23:01

Pediatric Study Demonstrated Improvements in Rickets Severity, Growth, Pain and Physical Activity in Children with Debilitating, Lifelong Hereditary Disease NOVATO, Calif., TOKYO, JAPAN, and LONDON, May 23, 2018 (GLOBE [...]

Cytori Therapeutic’s common stock to begin trading on adjusted basis on May 24, following one-for-ten reverse split

23/05/2018 - 22:55

SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced that the Company effected a reverse stock split that became effective on May 23, 2018 at a [...]

Amarin to Present at the Jefferies Global Healthcare Conference

23/05/2018 - 22:30

BEDMINSTER, N.J., and DUBLIN, Ireland, May 23, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Retrophin Receives Workplace Excellence Award

23/05/2018 - 22:30

Peter Barron Stark Companies honors Retrophin for its continued commitment to workplace and cultural excellence SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that it has [...]

The Cooper Companies Announces Executive Management Changes

23/05/2018 - 22:15

Holly Sheffield to Join as EVP, Chief Strategy Officer Robert Auerbach Appointed President, CooperSurgical PLEASANTON, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced the [...]

Myriad Announces Seven New Payer Coverage Decisions for Prolaris®

23/05/2018 - 22:05

Coverage Policies Consistent with Recently Updated NCCN Guidelines SALT LAKE CITY, May 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a worldwide leader in personalized medicine, today announced [...]

Tonix Pharmaceuticals to Present at the 2018 American Society of Clinical Psychopharmacology

23/05/2018 - 22:05

NEW YORK, May 23, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix) announced today that Gregory Sullivan, M.D., Chief Medical Officer of Tonix, will present at the 2018 American [...]

Thetis Pharmaceuticals Receives $1.9 Million Fast-Track NIH Grant to Advance Novel Inflammatory Bowel Disease Drug Pipeline Toward Clinical Investigation

23/05/2018 - 22:03

First-in-human studies targeted for 2019 BRANFORD, Conn., May 23, 2018 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals, a biopharmaceutical company developing novel therapies for treatment of inflammatory bowel disease (IBD [...]

Integra LifeSciences to Present at Healthcare Conferences in June 2018

23/05/2018 - 22:01

PLAINSBORO, N.J., May 23, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, will present at the following healthcare conferences in June: On [...]

Emerald Health Sciences Inc.

23/05/2018 - 21:53

Vancouver, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) -- Emerald Health Sciences Inc. (the “ Acquiror ”) announces that on May 22, 2018, it sold, through a secondary offering, 2,000,000 common shares (the “ Shares [...]